Variation in Survival Among Patients With Acute Lymphocytic Leukemia

Author:

ZIPPIN C.12,CUTLER S. J.13,REEVES W. J.14,LUM D.12

Affiliation:

1. University of California, San Francisco Medical Center, San Francisco, Calif., and the End Results Section, National Cancer Institute, National Institutes of Health, Bethesda, Md.

2. University of California, San Francisco Medical Center, San Francisco, Calif.

3. End Results Section, National Institutes of Health, National Cancer institute, Bethesda, Md.

4. M. D. Anderson Hospital and Tumor Institute, Houston, Texas; formerly at University of California, San Francisco Medical Center, San Francisco, Calif.

Abstract

Abstract Survival of 873 acute lymphocytic leukemia patients has been reviewed in relation to a number of patient and disease characteristics at first hospital admission. Study of survival by individual years of age at diagnosis led to the selection of five age intervals: 1-3, 4-10, 11-19, 20-49, and 50 years and over. For each sex the survival after age 10 was considerably poorer than for the younger ages. The best survival for any age-sex group was that for girls 4-10, who had a median survival time of 14.0 months compared with an overall median survival time of 7.8 months for patients of both sexes over 1 year of age. We attempted to determine whether a favorable distribution of other factors related to survival might work to the advantage of girls in the 4-10 year age group. However, in studying factors such as symptoms and hematological characteristics it was the pattern, rather than the exception, to find within most levels of a characteristic under study, that girls 4-10 had the best survival. It would be interesting and potentially valuable to see whether the findings in this study are confirmed in other series. If a specific age-sex group tends to maintain a superior survival pattern, additional exploration of prognostic factors may uncover important leads concerning the biology of the disease.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3